Literature DB >> 34904399

Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021.

Stephan von Haehling1, Andrew J S Coats2, Stefan D Anker3.   

Abstract

The Journal of Cachexia, Sarcopenia and Muscle (JCSM) aims to publish articles with relevance to wasting disorders and illnesses of the muscle in the broadest sense. In order to avoid publication of inappropriate articles and to avoid protracted disputes, the Editors have established ethical guidelines that detail a number of regulations to be fulfilled prior to submission to the journal. This article updates the principles of ethical authorship and publishing in JCSM and its two daughter journals JCSM Rapid Communication and JCSM Clinical Reports. We require the corresponding author, on behalf of all co-authors, to certify adherence to the following principles: All authors listed on a manuscript considered for publication have approved its submission and (if accepted) approve publication in the journal; Each named author has made a material and independent contribution to the work submitted for publication; No person who has a right to be recognized as author has been omitted from the list of authors on the submitted manuscript; The submitted work is original and is neither under consideration elsewhere nor that it has been published previously in whole or in part other than in abstract form; All authors certify that the submitted work is original and does not contain excessive overlap with prior or contemporaneous publication elsewhere, and where the publication reports on cohorts, trials, or data that have been reported on before the facts need to be acknowledged and these other publications must be referenced; All original research work has been approved by the relevant bodies such as institutional review boards or ethics committees; All relevant conflicts of interest, financial or otherwise, that may affect the authors' ability to present data objectively, and relevant sources of funding of the research in question have been duly declared in the manuscript; All authors certify that they will submit the original source data to the editorial office upon request; The manuscript in its published form will be maintained on the servers of the journal as a valid publication only as long as all statements in these guidelines remain true; If any of the aforementioned statements ceases to be true, the authors have a duty to notify as soon as possible the Editor-in-Chief of the journal, so that the available information regarding the published article can be updated and/or the manuscript can be withdrawn.
© 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Entities:  

Keywords:  Ethical guidelines; Publishing

Year:  2021        PMID: 34904399      PMCID: PMC8718061          DOI: 10.1002/jcsm.12899

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


The Journal of Cachexia, Sarcopenia and Muscle (JCSM) is a peer‐reviewed international journal dedicated to publishing materials that are related to cachexia and sarcopenia as well as to body composition and its physiological and pathophysiological changes during the life span and in different illnesses from all fields of the life sciences. JCSM was founded in 2010 and has attracted interest by both clinicians and researchers, which is buttressed by increasing download numbers, citations, submissions, and by an increasing impact factor. , Submissions to JCSM are now coming from the entire globe. , , The authors of these ethical guidelines, who are editing four peer‐reviewed journals including—besides JCSM—the two daughter journals of JCSM, that is JCSM Clinical Reports and JCSM Rapid Communications as well as ESC Heart Failure, share the view that academic publishing depends, to a great extent, on trust between authors, reviewers, editors, and the academic and lay public. , , Scientific publications are made in an environment of many competing interests that may be commercial (in many different ways), intellectual, and/or political in nature. Some of these competing interests create conflicts of interest. In this context, the Editors of JCSM see it as their duty to promote transparency and research integrity. And, as this is an ongoing effort, we wish to recall the validity and update the statements on ethical publishing made by us before. , , , All authors wishing to publish in JCSM and its two daughter journals JCSM Clinical Reports and JCSM Rapid Communications are required to certify that they comply with the guidelines of publishing in JCSM outlined in the succeeding text. This should be performed by stating as part of the published manuscript that ‘All authors of this manuscript comply with the guidelines of ethical authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle’, providing reference to these guidelines by referencing this article, for example by referencing it in brackets or as part of the list of references. Specifically, the corresponding author, on behalf of all co‐authors, Certifies that all authors listed on a manuscript considered for publication have approved its submission and (if accepted) approve publication in JCSM as provided; Certifies that each named author has made a material and independent contribution to the work submitted for publication—authorship credit should be based only on, first a substantial contribution to conception and design, or acquisition of data, or analysis and interpretation of data, and second drafting the article or revising it critically for important intellectual content; Certifies that no person who has a right to be recognized as author has been omitted from the list of authors on the submitted manuscript; Certifies that the submitted work is original and is neither under consideration elsewhere nor that it has been published previously in whole or in part other than in abstract form; Certifies that all authors certify that the submitted work is original and does not contain excessive overlap with prior or contemporaneous publication elsewhere, and where the publication reports on cohorts, trials, or data that have been reported on before the facts need to be acknowledged and these other publications must be referenced (of note, the degree of overlap and difference must be fully described and justified; excessive overlap that is not justified in a cover letter will lead to rejection or withdrawal of the manuscript); Certifies that all original research work has been approved by the relevant bodies such as institutional review boards or ethics committees (of note, this rule is not applicable for review articles or editorial comments that give reference to other people's work); Certifies that all relevant conflicts of interest, financial or otherwise, that may affect the authors' ability to present data objectively, and relevant sources of funding of the research in question have been duly declared in the manuscript; All authors certify that they will submit the original source data to the editorial office upon request; 1 Certifies that the manuscript in its published form will be maintained on the servers of JCSM as a valid publication only as long as all statements in the guidelines on ethical publishing remain true; If any of the aforementioned statements ceases to be true, the authors have a duty to notify as soon as possible the Editors of JCSM, JCSM Rapid Communication, and JCSM Clinical Reports, respectively, so that the available information regarding the published article can be updated and/or the manuscript can be withdrawn. We will continue our editorial work for the JCSM journal family, and the increasing number of submissions underscores the continuing need for such a niche journal and its two daughter journals, JCSM Rapid Communication and JCSM Clinical Reports. This is particularly so, because diagnostic tools have improved and overall awareness and research in cachexia and sarcopenia have increased. Nevertheless, there still remains a great unmet medical need, because cachexia and sarcopenia are still associated with an unacceptably high burden of morbidity and mortality affecting patients, families, care‐givers, and healthcare systems, and no new therapies exist yet. Despite the existing wish to advance our knowledge, we recognize that the world is not free of scientific misconduct, which can come in many ways. We are happy to report that only very few problems have arisen in the past 11 years and no published paper had to be withdrawn so far. The Editors of JCSM aim to continue to keep a close eye on these issues, and we need reviewers to help in this. We simply ask that authors play fair to the academic community and the public at large and then none of this will ever be an issue. We want to take a lead in identifying, notifying, investigating, and reporting all occurrences of scientific misconduct related to JCSM. We will withdraw papers, if significant problems come to our attention. This shall be no surprise to anyone when it has to occur. As stated before, academic publishing is built on trust. We want JCSM to be a trusted and valued source of best available scientific knowledge in the field. We hope that, together, we can achieve this objective and our journal can succeed in this ambition.
  14 in total

1.  Whether industry-supported or otherwise, trust is key to the acceptance of all research.

Authors:  Michael Glick
Journal:  J Am Dent Assoc       Date:  2010-02       Impact factor: 3.634

2.  Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.

Authors:  Stephan von Haehling; John E Morley; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-10-26       Impact factor: 12.910

3.  Best Practice Guidelines on Publication Ethics: a publisher's perspective.

Authors:  Chris Graf; Elizabeth Wager; Alyson Bowman; Suzan Fiack; Diane Scott-Lichter; Andrew Robinson
Journal:  Int J Clin Pract Suppl       Date:  2007-01

4.  Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017.

Authors:  Stephan von Haehling; John E Morley; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-11-03       Impact factor: 12.910

5.  Myopenia and precision (P4) medicine.

Authors:  John E Morley; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-09-24       Impact factor: 12.910

6.  Time to jump on the bandwagon: the Journal of Cachexia, Sarcopenia and Muscle in 2018.

Authors:  Stephan von Haehling; Markus S Anker; Nicole Ebner; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-10-11       Impact factor: 12.910

7.  Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.

Authors:  Markus S Anker; Richard Holcomb; Maurizio Muscaritoli; Stephan von Haehling; Wilhelm Haverkamp; Aminah Jatoi; John E Morley; Florian Strasser; Ulf Landmesser; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-02       Impact factor: 12.910

8.  Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015.

Authors:  Stephan von Haehling; John E Morley; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-11-11       Impact factor: 12.910

9.  Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017.

Authors:  Stephan von Haehling; Nicole Ebner; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-10       Impact factor: 12.910

10.  More variety with the Journal of Cachexia, Sarcopenia and Muscle: JCSM Clinical Reports and JCSM Rapid Communications have both gone live.

Authors:  Stefan D Anker; Stephan von Haehling; Andrew J S Coats
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-04       Impact factor: 12.910

View more
  91 in total

1.  Urinary creatinine excretion is an indicator of physical performance and function.

Authors:  Milou M Oosterwijk; Niala den Braber; Stephan J L Bakker; Gozewijn D Laverman
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-27       Impact factor: 12.910

2.  Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.

Authors:  Kun-Chang Wu; Po-Chen Chu; Yu-Jung Cheng; Chia-Ing Li; Jingkui Tian; Hsing-Yu Wu; Szu-Hsien Wu; Yi-Chun Lai; Hsiang-Han Kao; Ao-Lin Hsu; Hsiang-Wen Lin; Chih-Hsueh Lin
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-06-19       Impact factor: 12.063

3.  Sarcopenia and catastrophic health expenditure by socio-economic groups in China: an analysis of household-based panel data.

Authors:  Chen Ye; Xu Zheng; Sumiya Aihemaitijiang; Ruoyu Wang; Mairepaiti Halimulati; Xiaojie Huang; Zhaofeng Zhang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-04-26       Impact factor: 12.063

4.  The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.

Authors:  Corine de Jong; Najiba Chargi; Gerarda J M Herder; Simone W A van Haarlem; Femke van der Meer; Anne S R van Lindert; Alexandra Ten Heuvel; Jan Brouwer; Pim A de Jong; Lot A Devriese; Alwin D R Huitema; Toine C G Egberts; Remco de Bree; Vera H M Deneer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-03-18       Impact factor: 12.063

5.  Clinical implications of low estimated protein intake in patients with heart failure.

Authors:  Koen W Streng; Hans L Hillege; Jozine M Ter Maaten; Dirk J van Veldhuisen; Kenneth Dickstein; Leong L Ng; Nilesh J Samani; Marco Metra; Piotr Ponikowski; John G Cleland; Stefan D Anker; Simon P R Romaine; Kevin Damman; Peter van der Meer; Chim C Lang; Adriaan A Voors
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-04-14       Impact factor: 12.063

6.  The Obesity Paradox in Cancer: Is Bigger Better?

Authors:  Barry J A Laird; Richard J E Skipworth
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-05-04       Impact factor: 12.063

7.  Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021.

Authors:  Stephan von Haehling; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-12-13       Impact factor: 12.910

8.  Altered features of body composition in older adults with type 2 diabetes and prediabetes compared with matched controls.

Authors:  Kirsten E Bell; Michael T Paris; Egor Avrutin; Marina Mourtzakis
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-16       Impact factor: 12.910

9.  Human pancreatic tumour organoid-derived factors enhance myogenic differentiation.

Authors:  Rianne D W Vaes; David P J van Dijk; Elham Aïda Farshadi; Steven W M Olde Damink; Sander S Rensen; Ramon C Langen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-11       Impact factor: 12.910

10.  Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice.

Authors:  Agnès Martin; Josiane Castells; Valentine Allibert; Andréa Emerit; Cindy Zolotoff; Victoire Cardot-Ruffino; Yann S Gallot; Barbara Vernus; Véronique Chauvet; Laurent Bartholin; Laurent Schaeffer; Anne-Cécile Durieux; Christophe Hourdé; François B Favier; Laetitia Mazelin; Damien Freyssenet
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-03-11       Impact factor: 12.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.